Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR
- 1 August 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 202 (2) , 176-181
- https://doi.org/10.1097/00000658-198508000-00007
Abstract
Eight of 46 (17.4%) patients treated in a trial of continuous hepatic artery infusion (CHAI) of fluorodeoxyuridine (FUDR) by Infusaid pump developed biliary strictures. The lesions were clinically, radiographically, and pathologically identical to the idiopathic sclerosing cholangitis frequently seen in association with inflammatory bowel disease. Treatment included immediate cessation of intraarterial FUDR and surgical or percutaneous drainage of the biliary tree if it was dilated. Two of the 8 patients died of the complication. Three patients stabilized after biliary system drainage and 2 patients improved on observation only. The pathogenesis of this complication is not understood. The report details the clinical and pathological features of this entity.This publication has 5 references indexed in Scilit:
- Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized studyCancer, 1985
- Sclerosing CholangitisAnnals of Surgery, 1984
- A Prospective Phase II Clinical Trial of Continuous FUDR Regional Chemotherapy for Colorectal Metastases to the LiverAnnals of Surgery, 1983
- Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump: A feasibility study in 50 patientsThe American Journal of Surgery, 1983
- Intrahepatic arterial infusion with 5-fluorouracilCancer, 1971